What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Medulloblastoma, Cancer research, Bioinformatics, Genetics and Pathology.
His Medulloblastoma study combines topics in areas such as Cancer, Clinical trial, Gene expression profiling, Genomics and Human genetics.
Stefan M. Pfister has included themes like Mutation, IDH1, Epigenetics and Exome in his Cancer research study.
His Exome study combines topics from a wide range of disciplines, such as APOBEC, Kataegis, Cytidine deaminase and DNA mismatch repair.
His Bioinformatics research is multidisciplinary, relying on both Survival rate and Retrospective cohort study.
As part of the same scientific family, Stefan M. Pfister usually focuses on Pathology, concentrating on Young adult and intersecting with Stage, Extent of resection, Predictive value of tests, Cytogenetics and Patient age.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- Signatures of mutational processes in human cancer (5372 citations)
- International network of cancer genome projects (1611 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Medulloblastoma, Pathology, DNA methylation and Internal medicine.
His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Histone, Gene and Carcinogenesis.
His Medulloblastoma study incorporates themes from Cancer, Wnt signaling pathway, Bioinformatics, Gene expression profiling and Sonic hedgehog.
He interconnects Transcriptome, Disease and Genomics in the investigation of issues within Bioinformatics.
His DNA methylation study results in a more complete grasp of Genetics.
His Internal medicine study which covers Oncology that intersects with Cohort.
He most often published in these fields:
- Cancer research (56.88%)
- Medulloblastoma (45.63%)
- Pathology (34.39%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (56.88%)
- DNA methylation (33.74%)
- Internal medicine (28.90%)
In recent papers he was focusing on the following fields of study:
Stefan M. Pfister mainly investigates Cancer research, DNA methylation, Internal medicine, Medulloblastoma and Oncology.
His studies examine the connections between Cancer research and genetics, as well as such issues in Epigenetics, with regards to Gene mutation.
His study in DNA methylation is interdisciplinary in nature, drawing from both Methylation, DNA and Sarcoma, Pathology.
His study looks at the intersection of Sarcoma and topics like Epigenomics with Cancer.
His research integrates issues of Ependymoma and MEDLINE in his study of Internal medicine.
The various areas that he examines in his Medulloblastoma study include Suppressor, Transcriptome, Germline and Sonic hedgehog, PTCH1.
Between 2019 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. (101 citations)
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. (101 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His scientific interests lie mostly in Cancer research, Internal medicine, DNA methylation, Medulloblastoma and Oncology.
His Cancer research research includes themes of Mutation, Histone H3, Chemotherapy and Carcinogenesis.
His work deals with themes such as Methylation profiling and MEDLINE, which intersect with Internal medicine.
His work investigates the relationship between DNA methylation and topics such as Pathology that intersect with problems in Methylation, Gene panel, YAP1 and YWHAE.
His Medulloblastoma research includes elements of Germline mutation, Transcriptome, Germline, Disease and PTCH1.
His studies deal with areas such as Craniospinal Irradiation, Disease specific and Glioma as well as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
